Publication Month: May 2022 | Report Code: TIPRE00005918 | No. of Pages: 175 | Category: Medical Device | Status: Published
Human Identification processes are used to prevent blood transfusion and associated complications by removing macroaggregates and leucocytes from the donor blood.
The rise of the human identification market is attributed to the government initiatives for forensic programs and new sampling methods and portable equipment supporting DNA phenotyping, immunochromatography, geolocation, and other advanced forensic techniques. However, the high cost associated with instruments used in genomic studies is acting as a hindrance to the human identification market’s growth.
Get more information on this report :
The growing support from governments, the rising number of public-private partnerships, and the increasing number of funding plans are aiding the medical devices industry in regions, such as Asia Pacific, Latin America, and the Middle East and Africa. In addition, countries in these regions offer lucrative opportunities for the industry's growth due to the ever-increasing population and large geriatric population. According to the Organization for Economic Co-operation and Development (OECD), in 2019, China was the leading spender on healthcare research and development. Such heavy investments in the development of the healthcare sector support the uptake of advanced technologies in this sector. Moreover, government initiatives have led to an increase in DNA testing. For instance, in 2019, China uses DNA to track its people, with the help of American expertise. As they developed a huge surveillance and control system, the Chinese authorities turned to a Massachusetts company and a prominent Yale researcher. China is now infiltrating the DNA of its population. Many people are concerned about China's growing genetic profile database, which has reignited the privacy controversy. The Chinese government's genome database is estimated to have over 140 million profiles, making it the largest DNA database in the world.
The governments of several countries in Asia and the Middle East and Africa offer tax incentives, cheaper land, incubators, and other instrument aids, and direct investments to encourage the local medical devices companies to expand their abilities and capacities. Countries, such as the UAE, Saudi Arabia, Oman, Muscat, Bahrain, Malaysia, Taiwan, Singapore, India, China, and Japan, have proven to be the most favorable destinations for human identification market players to establish and expand their businesses.
Several Asian governments have expressed interest in forensic research and the development and production of human identification products. The Taiwanese government invested US$ 3 million in March 2013 to speed up equipment procurement projects for its forensic laboratories, among other ongoing programs in the country. Further, the Indian government plans to develop a national criminal DNA fingerprint database. Developing such a database will require high-end instruments and consumables. For instance, in September 2020, Aegea Biotechnologies, Inc. received a Japanese patent for its amplification improvement platform and switch mutation detection solution for the diagnosis of genetic and rare disorders. Likewise, DNA paternity testing is gaining traction in the region. In Japan, paternity testing using DNA has lately been more readily available. DTC (direct-to-consumer) paternity testing has primarily been considered in relation to genetic disease and socially desired traits which are expected to boost the demand for human identification market in the coming years.
Based on products and services, the human identification market is segmented into consumables, services, instruments, and software. The consumables segment held the largest share of the market in 2021. It is anticipated to register the highest CAGR in the market during the forecast period. Consumables in the human identification market are fundamental kits and chemicals required for the human identification processes such as capillary electrophoresis, microfluidics, polymerase chain reaction (PCR), nucleic acid purification and extraction, automated liquid handling, microarrays, next-generation sequencing (NGS), rapid DNA analysis, and others.
Get more information on this report :
Based on technology, the human identification market is segmented into capillary electrophoresis, polymerase chain reaction, nucleic acid purification and extraction, automated liquid handling, microarrays, next-generation sequencing, and rapid DNA analysis. The capillary electrophoresis segment held the largest share of the market in 2021. However, polymerase chain reaction is anticipated to register the highest CAGR in the human identification market during the forecast period.
Based on application, the human identification market is segmented into forensic applications, paternity identification, and other applications. The forensic application segment led the market in 2021 and is anticipated to register a highest CAGR in the market during the forecast period.
Based on end user, the human identification market is segmented into forensic laboratories, research and academic centers, and government institutes. The forensic laboratories segment held the largest share of the market in 2021 and is estimated to register the highest CAGR in the market during the forecast period.
Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the human identification market players focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally. The human identification market is anticipated to flourish in the coming years due to the development of innovative products by players.
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.